Blitz Bureau
NEW DELHI: The Goods and Services Tax (GST) Council’s decision to slash GST on several cancer-related and other essential medicines is a “commendable step”, said the Indian Medical Association (IMA) on August 25. In a statement, the IMA noted that the move will make healthcare more affordable and accessible for millions of patients across the country.
“The reduction in GST on critical drugs reflects the Government’s commitment to strengthening public health infrastructure and supporting those battling serious medical conditions such as cancer, chronic diseases, and life-threatening infections,” the IMA said. The statement comes as the government is working to reduce GST on a range of essential and life-saving medicines as part of its broader tax reforms.
For cancer drugs and other critical treatments, the proposed changes include lowering GST rates from 12 per cent to 5 per cent, and in some cases bringing them down to nil. Medicines used in the treatment of rare diseases are also under consideration for exemption.
The move aims to ensure that high-cost therapies, which already place a heavy financial strain on patients and their families, become more affordable and widely accessible. Notably, the association urged the government and GST Council to further alleviate the burden on patients and healthcare providers by enabling GST exemption on lifesaving and essential medicines, including on drugs used for chemotherapy, immunotherapy, and targeted therapies; insulin and oral agents used for diabetes.
